Mapping of glutamate metabolism using 1H FID-MRSI after oral administration of [1-13C]Glc at 9.4 T

Theresia Ziegs, Loreen Ruhm, Andrew Wright, Anke Henning

Research output: Contribution to journalArticlepeer-review


Glutamate is the major excitatory transmitter in the brain and malfunction of the related metabolism is associated with various neurological diseases and disorders. The observation of labeling changes in the spectra after the administration of a 13C labelled tracer is a common tool to gain better insights into the function of the metabolic system. But so far, only a very few studies presenting the labeling effects in more than two voxels to show the spatial dependence of metabolism. In the present work, the labeling effects were measured in a transversal plane in the human brain using ultra-short TE and TR 1H FID-MRSI. The measurement set-up was most simple: The [1-13C]Glc was administered orally instead of intravenous and the spectra were measured with a pure 1H technique without the need of a 13C channel (as Boumezbeur et al. demonstrated in 2004). Thus, metabolic maps and enrichment curves could be obtained for more metabolites and in more voxels than ever before in human brain. Labeling changes could be observed in [4–13C]glutamate, [3–13C]glutamate+glutamine, [2–13C]glutamate+glutamine, [4–13C]glutamine, and [3–13C]aspartate with a high temporal (3.6 min) and spatial resolution (32 × 32 grid with nominal voxel size of 0.33 µL) in five volunteers.

Original languageEnglish (US)
Article number119940
StatePublished - Apr 15 2023


  • Glutamatergic metabolism
  • Human brain
  • Proton magnetic resonance spectroscopy imaging
  • Ultra-high field strengths
  • [1-13C]Glc labeling

ASJC Scopus subject areas

  • Neurology
  • Cognitive Neuroscience


Dive into the research topics of 'Mapping of glutamate metabolism using 1H FID-MRSI after oral administration of [1-13C]Glc at 9.4 T'. Together they form a unique fingerprint.

Cite this